Skip to main content

Endothelial Function and Insights for Prevention

  • Chapter
Book cover Preventive Cardiology

Abstract

When William Harvey described the circulatory system in 1628, it was believed that the endothelium was an inert organ whose mere function was to line the arteries. Extensive research, however, has demonstrated that the endothelium is one of the most sophisticated organs in the system, playing a substantial role in the homeostasis of the circulatory system (1). The endothelium serves as one of the largest paracrine organs in the body by playing a pivotal role in the regulation of such important tasks as vascular growth, vascular tone, and hemostasis. Additionally, the endothelium maintains the balance between opposing states: vasodilation vs vasoconstriction, growth promotion vs inhibition, antithrombosis vs fibrinolysis, antioxidation vs oxidation, and anti-inflammation vs proinflammation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Luscher TF, Rubanyi GM, Masaki T, Vane JR, Vanhoutte PM. Endothelial control of vascular tone and growth. Circulation 1993; 87(Suppl V):VI–V2.

    Google Scholar 

  2. Furchgott RF. The discovery of endothelium-dependent relaxation. Circulation 1993; 87(Suppl V): V3–V8.

    CAS  Google Scholar 

  3. Furchgott RF, Zawadrki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373–376.

    Article  PubMed  CAS  Google Scholar 

  4. Vanhoutte PM, Perrault LP, Vilaine JP. Endothelial dysfunction and vascular disease. In: Rubanyi GM, Dzau VJ, eds. The Endothelium in Clinical Practice. Source and Target of Novel Therapies. Marcel Dekker, New York, 1997, pp. 265–289.

    Google Scholar 

  5. Parkinson IF, Phillips GB. Nitric oxide synthases: enzymology and mechanism-based inhibitors. In: Rubanyi GM, Dzau VJ, eds. The Endothelium in Clinical Practice. Source and Target of Novel Therapies. Marcel Dekker, New York, 1997, pp. 95–123.

    Google Scholar 

  6. Ikeda U, Shimada K. Nitric oxide and cardiac failure. Clin Cardiol 1997; 20: 837–841.

    Article  PubMed  CAS  Google Scholar 

  7. Busse R, Mulsch A, Fleming I, Hecker M. Mechanisms of nitric oxide release from the vascular endothelium. Circulation 1993; 87(Suppl V): V18–V25.

    CAS  Google Scholar 

  8. Pohl U, Holte J, Busse R, Bassenge E. Crucial role of endothelium in the vasodilator response to increase to increase flow in vivo. Hypertension 1986; 8: 37–44.

    PubMed  CAS  Google Scholar 

  9. Vanhoutte PM, Shimokawa H. Endothelium-derived relaxing factor and coronary vasospasm. Circulation 1989; 80: 1–9.

    PubMed  CAS  Google Scholar 

  10. Gries A, Bode C, Peter K, et al. Inhaled nitric oxide inhibits platelet aggregation, P-selectin expression, and fibrinogen in vitro and in vivo. Circulation 1998; 97: 1481–1487.

    PubMed  CAS  Google Scholar 

  11. Scoft-Burden T, Vanhoutte PM. The endothelium as a regulator of vascular smooth muscle proliferation. Circulation 1993; 87(Suppl V): V51–V55.

    Google Scholar 

  12. Mehta JL, Yang BC. Prostacyclin and thromboxane: role in ischemic heart disease. In: Rubanyi GM, Dzau VJ, eds. The Endothelium in Clinical Practice. Source and Target of Novel Therapies. Marcel Dekker, New York, 1997, pp. 45–69.

    Google Scholar 

  13. Groves P, Kurz S, Hanjorg J, Drexler H. Role of endogenous bradykinin in human coronary vasomotor control. Circulation 1995; 92: 3424–3430.

    PubMed  CAS  Google Scholar 

  14. Campbell WE, Gebredmedhin D, Pratt PF, Harder DR. Identification of oxyeicosatrienoic acids as endothelium-derived hyperpolarizing. Circ Res 1996; 78: 415–423.

    PubMed  CAS  Google Scholar 

  15. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411–415.

    Article  PubMed  CAS  Google Scholar 

  16. Masaki T. Overview: reduced sensitivity of vascular response to endothelin. Circulation 1993; 87(Suppl V): V33–V35.

    CAS  Google Scholar 

  17. Stewart D. Impact of endothelin-1 on vascular structure and function. A symposium: endothelial function and cardiovascular disease: potential mechanisms and interventions. Am J Cardiol 1998; 82: 14S–15S.

    PubMed  CAS  Google Scholar 

  18. Luscher TF, Boulanger CM, Yang Z, Noll G, Dohi Y. Interactions between endothelium-derived relaxing and contracting factors in health and cardiovascular disease. Circulation 1993; 87(Suppl V): V36–V44.

    CAS  Google Scholar 

  19. Kalafatis M, Egan J, Maim K. Coagulation factors. In: Rubanyi GM, Dzau VJ, eds. The Endothelium in Clinical Practice. Source and Target of Novel Therapies. Marcel Dekker, New York, 1997, pp. 245–264.

    Google Scholar 

  20. Dormandy J, Belcher G. Clinical use of prostacyclin. In: Rubanyi GM, Dzau VJ, eds. The Endothelium in Clinical Practice. Source and Target of Novel Therapies. Marcel Dekker, New York, 1997, pp. 71–94.

    Google Scholar 

  21. Ludmer FL, Selwyn AP, Shook TL, et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986; 315: 1046–1051.

    Article  PubMed  CAS  Google Scholar 

  22. Lefroy DC, Crake T, Uren NG, et al. Effect of inhibition of NO synthesis on epicardial coronary artery caliber and coronary flow in humans. Circulation 1993; 88: 43–54.

    PubMed  CAS  Google Scholar 

  23. Uehata A, Lieberman EH, Gerhard MD, et al. Noninvasive assessment of endothelium-dependent flow mediated dilation of the brachial artery. Vasc Med 1997; 2: 87–92.

    PubMed  CAS  Google Scholar 

  24. Anderson TJ, Uehata A, Gerhard MD, et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995; 26: 1235–1241.

    Article  PubMed  CAS  Google Scholar 

  25. Anderson TJ, Gerhard MD, Meredith IT, et al. Systemic nature of endothelial dysfunction in atherosclerosis. Am J Cardiol 1995; 75: 71B–74B.

    Article  PubMed  CAS  Google Scholar 

  26. Celerimajer DS, Sorensen K, Spiegelhalter DJ, et al. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol 1994; 24: 471–476.

    Article  Google Scholar 

  27. Hashimoto M, Akishita M, Eto M, et al. Modulation of endothelium-dependent flow-mediated dilatation of the brachial artery by sex and menstrual cycle. Circulation 1995; 92: 3431–3435.

    PubMed  CAS  Google Scholar 

  28. Lieberman EH, Gerhard M, Uehata A, et al. Estrogen improves endothelium dependent flow-mediated vasodilation in post menopausal women. Ann Intern Med 1994; 121: 936–941.

    PubMed  CAS  Google Scholar 

  29. Panza JA, Casino PR, Kiloyne CM, Quyyumi AA. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation 1993; 87: 1468–1474.

    PubMed  CAS  Google Scholar 

  30. Celermajer DS, Sorensen KE, Georgakopoulos D, et al. Cigarette smoking is associated 20 with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 1993;88:2149–2155.

    PubMed  CAS  Google Scholar 

  31. Celermajer DS, Adams MR, Clarkson P, et al. Passive smoking and impaired endothelium-dependent arterial dilation in healthy young adults. N Engl J Med 1996;334:150–154.

    Article  PubMed  CAS  Google Scholar 

  32. Santo-Tomas M, Lopez-Jimenez F, Aldrich HR, et al. Debunking the yuppie habit: cigars and endothe-lial function. J Am Coll Cardiol 1999;33:232A.

    Google Scholar 

  33. Heitzer T, Yla-Herttuala S, Luoma J, et al. Cigarette smoking potentiates endothelial dysfunction of fore-arm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL. Circulation 1996;93:1346–1353.

    PubMed  CAS  Google Scholar 

  34. Griendling KK, Alexander RW. Oxidative stress and cardiovascular disease. Circulation 1997;96:3264–3265.

    PubMed  CAS  Google Scholar 

  35. Reilly M, Delanty N, Lawson JA, Fitzgerald GA. Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation 1996;94:19–25.

    PubMed  CAS  Google Scholar 

  36. Creager MA, Cooke JP, Mendelsohn ME, et al. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest 1990;86:228–234.

    PubMed  CAS  Google Scholar 

  37. Zeiher AM, Drexler H, Saurbier B, et al. Correlation of endothelial dysfunction in coronary microcir-culation of hypercholesterolemic patients by L-arginine. Lancet 1991;338:1546–1550.

    Article  PubMed  Google Scholar 

  38. Verbeuren TJ, Jordaens FH, Zonnckeyn LL, et al. Effect of hypercholesterolemia on vascular reactivity in the rabbit. Circ Res 1986;58:552–564.

    PubMed  CAS  Google Scholar 

  39. Cohen RA, Zitnay KM, Haudenschild CC, et al. Loss of selective endothelial cell vasoactive functions caused by hypercholesterolemia in pig coronary arteries. Circ Res 1988;63:903–910.

    PubMed  CAS  Google Scholar 

  40. Shimokawa H, Vanhoutte RM. Impaired endothelium-dependent relaxation to aggregating platelets and related vasoactive substances in porcine coronary arteries in hypercholesterolemia and atherosclerosis. Circ Res 1989;64:900–914.

    PubMed  CAS  Google Scholar 

  41. Galle J, Mulsch A, Busse R, et al. Effects of native and oxidized low density lipoproteins on formation and inactivation of EDRF. Arterioscler Thromb 1991;11:198–203.

    PubMed  CAS  Google Scholar 

  42. Tagawa H, Tomoike H, Nakamura M. Putative mechanisms of the impairment of endothelium-depen-dent relaxation of the aorta with atheromatous plaque in heritable hyperlipidemic rabbits. Circ Res 1991;68:330–337.

    PubMed  CAS  Google Scholar 

  43. Steinberg D. Oxidative modification of LDL and atherogenesis. Circulation 1997;95:1062–1071.

    PubMed  CAS  Google Scholar 

  44. Cooke JP, Dzau VJ, Creager MA. Endothelial dysfunction in hypercholesterolemia is corrected by l-arginine. Basic Res Cardiol 1991;86(Suppl 2):173–181.

    PubMed  Google Scholar 

  45. Creager MA, Gallagher SJ, Girerd XJ, et al. L-arginine improves endothelium dependent vasodilation in hypercholesterolemic humans. J Clin Invest 1992;90(4):1248–1253.

    PubMed  CAS  Google Scholar 

  46. Casino PR, Kilcoyne CM, Quyyumi AA, et al. The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients. Circulation 1993;88:2541–2547.

    PubMed  CAS  Google Scholar 

  47. Sorensen KE, Celermajer DS, Georgakopoulos D, et al. Impairment of endothelium-dependent dilation is an early event in children with familiar hypercholesterolimia and is related to the lipoprotein (a) level. J Clin Invest 1994;93:50–55.

    PubMed  CAS  Google Scholar 

  48. Steinberg PR, Bayazeed B, Hook G, et al. Endothelial dysfunction is associated with cholesterol levels in the high normal range in humans. Circulation 1997;96:3287–3293.

    PubMed  CAS  Google Scholar 

  49. Leung WH, Lau CP, Wong CK. Beneficial effect of cholesterol-lowering therapy on coronary endot-helium-dependent relaxation in hypercholesterolemic patients. Lancet 1993;341:1496–1500.

    Article  PubMed  CAS  Google Scholar 

  50. Anderson TJ, Meredith IT, Yeung AC, et al. The effect of cholesterol lowering and antioxidant therapy on endothelium in patients with coronary artery disease. N Engl J Med 1994;332:488–493.

    Article  Google Scholar 

  51. Treasure CB, Klein JL, Weintraub WS, et al. Beneficial effects of cholesterol lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med 1994;332:481–487.

    Article  Google Scholar 

  52. Schmieder RE, Schobel HP. Is endothelial dysfunction reversible? Am J Cardiol 1995;76(2):117A–121A.

    Article  PubMed  CAS  Google Scholar 

  53. Berkenboom F, Langer I, Carpentier Y, Grosfils K, Fontaine J. Ramipril prevents endothelial dysfunc-tion induced by oxidized low-density lipoproteins. Hypertension 1997;30:371–376.

    PubMed  CAS  Google Scholar 

  54. Creager MA, Roddy MA. Effect of captopril and enalapril on endothelial function in hypertensive patients. Hypertension 1994;24:499–505.

    PubMed  CAS  Google Scholar 

  55. Schlaifer JD, Wargovich TJ, O’Neill B, et al. Effects of quinapril on coronary blood flow in coronary artery disease patients with endothelial dysfunction. J Am Coll Cardiol 1997;80:1594–1597.

    CAS  Google Scholar 

  56. Johnstone MT, Creager SJ, Scales KM, et al. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 1993;88:2510–2516.

    PubMed  CAS  Google Scholar 

  57. Williams SB, Cusco JA, Roddy MA, et al. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 1996;27:567–574.

    Article  PubMed  CAS  Google Scholar 

  58. Cosentino F, Hishikawa K, Katusic ZS, Luscher TF. High glucose increases nitric oxide synthase expres-sion and superoxide anion generation in human aortic endothelial cells. Circulation 1997;96:25–28.

    PubMed  CAS  Google Scholar 

  59. Zeiher AM, Drexler H, Saurbier B, Just H. Endothelium mediated coronary blood flow modulation in humans: effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J Clin Invest 1993;92:652–662.

    PubMed  CAS  Google Scholar 

  60. Barton M, Cosentino F, Brandes RP, et al. Anatomical heterogeneity of vascular aging: role of nitric oxide and endothelin. Hypertension 1997;30:817–824.

    PubMed  CAS  Google Scholar 

  61. Woo KS, Chook F, Lolin YI, et al. Hyperhomocystein(e)imia is a risk factor for arterial endothelial dysfunction in humans. Circulation 1997;96:2542–2544.

    PubMed  CAS  Google Scholar 

  62. Levine GN, Frei B, Koulouris SN, et al. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 1996;93:1107–1113.

    PubMed  CAS  Google Scholar 

  63. Ting HH, Timimi FK, Boles KS, et al. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 1996;97:22–28.

    Article  PubMed  CAS  Google Scholar 

  64. Vogel RA, Correti MC, Plotnick GD. Effect of a single high-fat meal on endothelial function in healthy subjects. Am J Cardiol 1997;79:350–354.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Lieberman, E.H., Garces, M.R., Lopez-Jimenez, F. (2006). Endothelial Function and Insights for Prevention. In: Foody, J.M. (eds) Preventive Cardiology. Contemporary Cardiology. Humana Press. https://doi.org/10.1007/978-1-59745-096-6_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-096-6_2

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-521-7

  • Online ISBN: 978-1-59745-096-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics